NEW YORK (dpa-AFX) - The US investment bank Goldman Sachs has left its rating for Carl Zeiss Meditec at "Sell" with a target price of 90 euros. The midpoint of the lowered target range for the operating result (EBIT) is about 30 percent below the market consensus, analyst Richard Felton wrote in his first reaction on Monday./ag/gl

Publication of the original report: 17.06.2024 / 10:28 / BST Initial dissemination of the original report: Date not specified in report / Time not specified in report / Time zone not specified in report

-----------------------

dpa-AFX Broker - the Trader News from dpa-AFX

-----------------------